Company Profiles

driven by the PitchBook Platform

OyaGen

Description

Developer of novel pharmaceutical therapies designed to exploits RNA editing and DNA editing enzymes. The company's novel pharmaceutical therapies harness the editing process of the enzymes which chemically alter RNA or DNA molecules and thereby change the genetic code, enabling physicians to treat Human Immunodeficiency Virus in an enhanced way.

2003

Founded

PRIVATE

Status

Grant

Latest Deal Type

$1.3M

Latest Deal Amount

$21M

Total Amount Raised

6

Investors

Description

Developer of novel pharmaceutical therapies designed to exploits RNA editing and DNA editing enzymes. The company's novel pharmaceutical therapies harness the editing process of the enzymes which chemically alter RNA or DNA molecules and thereby change the genetic code, enabling physicians to treat Human Immunodeficiency Virus in an enhanced way.

Website:

www.oyageninc.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Discovery Tools (Healthcare)
Drug Discovery

Primary Office

Rochester BioVenture Center, Room 151 77 Ridgeland Road Henrietta, NY 14623United States +1 (585) 697-4351
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore OyaGen's full profile, request a free trial.

OyaGen Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

OyaGen Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Empire State DevelopmentLimited Partner000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
National Institutes of HealthAccelerator/Incubator000 0000000 0000
New York State Common Retirement FundLimited PartnerMinority000 0000000 0000
Trillium GroupPE/BuyoutMinority000 0000000 0000
Empire State Development Limited Partner
Individual Investor Angel (individual)
National Institutes of Health Accelerator/Incubator
New York State Common Retirement Fund Limited Partner
Trillium Group PE/Buyout

OyaGen Executive Team (10)

NameTitleBoard
Seat
Contact
Info
Thomas FitzgeraldChief Operating Officer
Harold SmithFounder, President, Chief Executive Officer & Board Member
Kevin PhelpsBoard Member & Chief Financial Officer & Treasurer
Ryan Bennett Ph.DChief Scientific Officer & Laboratory Director
Jason SalterScientist
Thomas Fitzgerald Chief Operating Officer
Harold Smith Founder, President, Chief Executive Officer & Board Member
Kevin Phelps Board Member & Chief Financial Officer & Treasurer
Ryan Bennett Ph.D Chief Scientific Officer & Laboratory Director
Jason Salter Scientist

OyaGen Board Members (5)

NameRepresentingRoleSinceContact
Info
José CoronasTrillium GroupGeneral Partner000 0000
Kevin PhelpsOyaGenBoard Member & Chief Financial Officer & Treasurer000 0000
Richard McCloskeySelfBoard Member000 0000
Richard OgdenSelfBoard Member000 0000
Roscoe MooreSelfBoard Member000 0000
José Coronas General Partner Trillium Group
Kevin Phelps Board Member & Chief Financial Officer & Treasurer OyaGen
Richard McCloskey Board Member Self
Richard Ogden Board Member Self
Roscoe Moore Board Member Self
Request full access to PitchBook